Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00465101 · ClinicalTrials.gov registry record · Phase 4

A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization

A Phase 4 study of Benign Prostatic Hyperplasia, sponsored by American Medical Systems.

Completed
Registry status
Phase 4
Development phase
150
Enrollment target
9
Study locations

NCT00465101 is a Phase 4 study of Benign Prostatic Hyperplasia that has completed, run by American Medical Systems. The registered enrollment target is 150 participants, below the 547-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (73% lower). The trial reports 9 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00465101, a Phase 4 study of Benign Prostatic Hyperplasia, has completed, sponsored by American Medical Systems.

COMPLETED
Registry status
Phase 4
Development phase
150 participants
Enrollment target
9
Study locations

Study Summary

To gain clinical experience with the GreenLight HPS System, a system designed to vaporize and coagulate tissue in the treatment of benign prostatic hyperplasia to reduce lower urinary tract symptoms.

Conditions Studied

Benign Prostatic Hyperplasia

Interventions

  • DEVICE GreenLight HPS

Study Locations (9)

California

  • UCLA - Los Angeles

Connecticut

  • Connecticut Clinical Reseach Center - Middlebury

Georgia

  • North Fulton Urology, P.C. - Roswell

Michigan

  • Affiliates in Urology - Detroit

New York

  • PC Group/Universtiy Urology Association - New York

Ohio

  • Glickman Urological Institute - Cleveland

Oklahoma

  • Oklahoma University Health Science Center_Urology - Oklahoma City

Texas

  • UT Southwestern Medical Center at Dallas - Dallas

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2007-05
Est. Completion 2013-01
Phase Phase 4

Sponsor

American Medical Systems

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00465101

The ClinicalTrials.gov registry entry for NCT00465101 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 547-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (73% lower). The listed sponsor is American Medical Systems, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which GreenLight HPS is the first listed.

NCT00465101 reports 9 study locations spanning 9 distinct geographic areas - top geographies include California, Connecticut, Georgia.

Frequently Asked Questions

What is clinical trial NCT00465101 about?

NCT00465101 is a clinical study titled "A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization". To gain clinical experience with the GreenLight HPS System, a system designed to vaporize and coagulate tissue in the treatment of benign prostatic hyperplasia to reduce lower urinary tract symptoms.

What is the current status of trial NCT00465101?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2007-05. Estimated completion is 2013-01.

What conditions does trial NCT00465101 study?

This clinical trial studies the following conditions: Benign Prostatic Hyperplasia.

What interventions are being tested in trial NCT00465101?

The interventions under investigation include: GreenLight HPS (DEVICE).

Who is sponsoring clinical trial NCT00465101?

This trial is sponsored by American Medical Systems, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00465101 being conducted?

This trial has 9 study locations across California, Connecticut, Georgia, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Benign Prostatic Hyperplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Benign Prostatic Hyperplasia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.